N-[3-amino-6-(5-fluorothiophen-2-yl)-2-pyridinyl]-3-fluoro-3-pyrimidin-2-ylpyrrolidine-1-carboxamide
C18H16F2N6OS — CID 163959213
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-amino-6-(5-fluorothiophen-2-yl)-2-pyridinyl]-3-fluoro-3-pyrimidin-2-ylpyrrolidine-1-carboxamide
N-[3-amino-6-(5-fluorothiophen-2-yl)-2-pyridinyl]-3-fluoro-3-pyrimidin-2-ylpyrrolidine-1-carboxamide (PubChem CID 163959213) has the molecular formula C18H16F2N6OS and a molecular weight of 402.43 g/mol. Its IUPAC name is N-[3-amino-6-(5-fluorothiophen-2-yl)-2-pyridinyl]-3-fluoro-3-pyrimidin-2-ylpyrrolidine-1-carboxamide.
Molecular Properties
| Compound Name | N-[3-amino-6-(5-fluorothiophen-2-yl)-2-pyridinyl]-3-fluoro-3-pyrimidin-2-ylpyrrolidine-1-carboxamide |
|---|---|
| PubChem CID | 163959213 |
| Molecular Formula | C18H16F2N6OS |
| Molecular Weight | 402.43 g/mol |
| Exact Mass | 402.11 |
| IUPAC Name | N-[3-amino-6-(5-fluorothiophen-2-yl)-2-pyridinyl]-3-fluoro-3-pyrimidin-2-ylpyrrolidine-1-carboxamide |
| SMILES | Nc1ccc(-c2ccc(F)s2)nc1NC(=O)N1CCC(F)(c2ncccn2)C1 |
| InChI | InChI=1S/C18H16F2N6OS/c19-14-5-4-13(28-14)12-3-2-11(21)15(24-12)25-17(27)26-9-6-18(20,10-26)16-22-7-1-8-23-16/h1-5,7-8H,6,9-10,21H2,(H,24,25,27) |
| InChIKey | SGAPJHWZWYFYTH-UHFFFAOYSA-N |
| XLogP | 3.42 |
| TPSA | 97.03 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 402.43 |
| LogP ≤ 5 | 3.42 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163959213 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.